| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0002-4312-08 | 0002-4312 | HUMAN PRESCRIPTION DRUG | Reyvow | lasmiditan | TABLET | ORAL | 20200131 | N/A | NDA | NDA211280 | Eli Lilly and Company | LASMIDITAN | 50 mg/1 | 2 BLISTER PACK in 1 CARTON (0002-4312-08) / 4 TABLET in 1 BLISTER PACK |
| 0002-4312-61 | 0002-4312 | HUMAN PRESCRIPTION DRUG | Reyvow | lasmiditan | TABLET | ORAL | 20210303 | N/A | NDA | NDA211280 | Eli Lilly and Company | LASMIDITAN | 50 mg/1 | 1 BLISTER PACK in 1 CARTON (0002-4312-61) / 4 TABLET in 1 BLISTER PACK |
| 0002-4312-62 | 0002-4312 | HUMAN PRESCRIPTION DRUG | Reyvow | lasmiditan | TABLET | ORAL | 20220228 | N/A | NDA | NDA211280 | Eli Lilly and Company | LASMIDITAN | 50 mg/1 | 1 BLISTER PACK in 1 CARTON (0002-4312-62) / 2 TABLET in 1 BLISTER PACK |
| 0002-4491-62 | 0002-4491 | HUMAN PRESCRIPTION DRUG | Reyvow | lasmiditan | TABLET | ORAL | 20220228 | N/A | NDA | NDA211280 | Eli Lilly and Company | LASMIDITAN | 100 mg/1 | 1 BLISTER PACK in 1 CARTON (0002-4491-62) / 2 TABLET in 1 BLISTER PACK |
| 0002-4491-61 | 0002-4491 | HUMAN PRESCRIPTION DRUG | Reyvow | lasmiditan | TABLET | ORAL | 20200131 | N/A | NDA | NDA211280 | Eli Lilly and Company | LASMIDITAN | 100 mg/1 | 1 BLISTER PACK in 1 CARTON (0002-4491-61) / 4 TABLET in 1 BLISTER PACK |
| 0002-4491-08 | 0002-4491 | HUMAN PRESCRIPTION DRUG | Reyvow | lasmiditan | TABLET | ORAL | 20200131 | N/A | NDA | NDA211280 | Eli Lilly and Company | LASMIDITAN | 100 mg/1 | 2 BLISTER PACK in 1 CARTON (0002-4491-08) / 4 TABLET in 1 BLISTER PACK |